Moderna, Inc. earnings per share and revenue

MRNA earnings per share for the last quarter are -3.07 USD whereas the estimation was -3.56 USD which accounts for 13.68% surprise. Company revenue for the same period amounts to 167.00 M USD despite the estimated figure of 93.26 M USD. Estimated earnings per share for the next quarter are -3.51 USD, and revenue is expected to reach 72.22 M USD. Also watch annual changes over time to get a bigger picture of MRNA earnings per share and revenue dynamics.